arrow
M

Melanie J. Davies

university of leicester
H指数:132
被引数:9.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Use of artificial intelligence in evidence synthesis for EASD guidelines: an EASD Guidelines Oversight Committee statement

人工智能在EASD指南证据综合中的应用:EASD指南监督委员会声明

2026-11-170
OAAI
Correction: Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

更正:2型糖尿病管理,2026年。美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)联合发布的共识报告

2026-10-280
OAAI
Management of type 2 diabetes, 2026. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

2型糖尿病管理,2026年。美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)的共识报告

2026-10-020
OAAI
Cardiovascular safety of orforglipron versus insulin glargine in adults with type 2 diabetes at increased cardiovascular risk (ACHIEVE-4): a phase 3, event-driven, randomised, open-label, non-inferiority, active comparator trial

与甘精胰岛素相比,奥福格利普龙在具有心血管风险增加的2型糖尿病成人中的心血管安全性(ACHIEVE-4):一项第3期、事件驱动、随机、开放标签、非劣效性、活性对照试验

2026-09-300
PRE
Towards harmonised accelerometer-derived physical activity: a comparability study across wrist, thigh, and hip wear locations

向着协调化的加速度计衍生身体活动:手腕、大腿和髋部佩戴位置的可比性研究

2026-09-150
OAAI
Anti-inflammatory effects of oral NLRP3 inhibition with ruvonoflast among individuals at elevated cardiovascular risk

口服NLRP3抑制剂ruvonoflast在心血管风险升高人群中的抗炎作用

JACC
IF0
2026-05-260
OAAI
Maintaining function and participation through tailored 24-hour movement behaviours for people living with multiple long-term conditions and frailty (The PERSONAL-AGILITY study): Protocol for a randomised controlled feasibility trial

针对患有多种长期疾病和虚弱症人群,通过定制化24小时运动行为维持功能与参与度(PERSONAL-AGILITY研究):一项随机对照可行性试验方案

2026-05-180
PRE
Body Mass Index and All-Cause, Cancer, and Cardiovascular Mortality in Adults Aged 16-50 Years With and Without Type 2 Diabetes: An Analysis of Primary Care Records in England

16-50岁成人群体中体质指数与全因、癌症和心血管死亡率的关系:一项基于英格兰初级保健记录的分析,包括有和无2型糖尿病的患者

2026-05-010
PRE
Sodium-glucose co-transporter 2 inhibitors and obesity-associated cancers in people with type 2 diabetes: A real-world observational study

Sodium-glucose co-transporter 2 inhibitors and obesity-associated cancers in people with type 2 diabetes: 一项真实世界观察性研究

2026-02-260
OAAI
Multi-organ proteomics identifies oxidative stress pathways underlying genetic and pharmacological SGLT2 suppression

多器官蛋白质组学鉴定遗传和药理学SGLT2抑制下的氧化应激通路

2026-01-010
OAAI
Frailty, diabetic foot ulceration and mortality in people diagnosed with type 2 diabetes: Multistate analysis of primary care patients in the UK clinical practice research datalink

虚弱、糖尿病足溃疡和死亡率在诊断为2型糖尿病的人群中:英国临床实践研究数据链中初级保健患者的多状态分析

2025-12-150
OAAI
Age at type 2 diabetes diagnosis and prevalence of obesity, hypertension, anxiety, and depression: a retrospective observational study

2型糖尿病诊断年龄与肥胖、高血压、焦虑和抑郁患病率:一项回顾性观察性研究

2025-12-130
PRE
The Effect of Increased Sodium Intake with a Carbohydrate-Rich Meal on Glucose Homeostasis in People without Diabetes after Roux-en-Y Gastric Bypass: a Proof-of-Concept, Randomized, Open-Label, Crossover Study

增加钠摄入与高碳水化合物餐对 Roux-en-Y 胃旁路术后非糖尿病患者葡萄糖稳态的影响:一项概念验证、随机、开放标签、交叉研究

2025-11-280
OAAI
Effects of semaglutide in obesity-related heart failure with preserved ejection fraction across the age spectrum: Findings from the STEP-HFpEF programme

司美格鲁肽在肥胖相关的心衰伴射血分数保留中不同年龄范围的效果:STEP-HFpEF项目的发现

2025-11-250
OAAI